219 related articles for article (PubMed ID: 25598326)
1. Anti-type II collagen immune complex-induced granulocyte reactivity is associated with joint erosions in RA patients with anti-collagen antibodies.
Manivel VA; Sohrabian A; Wick MC; Mullazehi M; Håkansson LD; Rönnelid J
Arthritis Res Ther; 2015 Jan; 17(1):8. PubMed ID: 25598326
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-augmented chemokine production induced by type II collagen containing immune complexes is mediated via TLR4 in rheumatoid arthritis patients.
Manivel VA; Sohrabian A; Rönnelid J
Eur J Immunol; 2016 Dec; 46(12):2822-2834. PubMed ID: 27621106
[TBL] [Abstract][Full Text] [Related]
3. High anti-collagen type-II antibody levels and induction of proinflammatory cytokines by anti-collagen antibody-containing immune complexes in vitro characterise a distinct rheumatoid arthritis phenotype associated with acute inflammation at the time of disease onset.
Mullazehi M; Mathsson L; Lampa J; Rönnelid J
Ann Rheum Dis; 2007 Apr; 66(4):537-41. PubMed ID: 17040962
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
5. Surface-bound anti-type II collagen-containing immune complexes induce production of tumor necrosis factor alpha, interleukin-1beta, and interleukin-8 from peripheral blood monocytes via Fc gamma receptor IIA: a potential pathophysiologic mechanism for humoral anti-type II collagen immunity in arthritis.
Mullazehi M; Mathsson L; Lampa J; Rönnelid J
Arthritis Rheum; 2006 Jun; 54(6):1759-71. PubMed ID: 16736518
[TBL] [Abstract][Full Text] [Related]
6. Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis.
Mullazehi M; Wick MC; Klareskog L; van Vollenhoven R; Rönnelid J
Arthritis Res Ther; 2012 May; 14(3):R100. PubMed ID: 22548748
[TBL] [Abstract][Full Text] [Related]
7. Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
Manivel VA; Mullazehi M; Padyukov L; Westerlind H; Klareskog L; Alfredsson L; Saevarsdottir S; Rönnelid J
Ann Rheum Dis; 2017 Sep; 76(9):1529-1536. PubMed ID: 28336519
[TBL] [Abstract][Full Text] [Related]
8. Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis.
Park SH; Min DJ; Cho ML; Kim WU; Youn J; Park W; Cho CS; Kim HY
Arthritis Rheum; 2001 Mar; 44(3):561-9. PubMed ID: 11263770
[TBL] [Abstract][Full Text] [Related]
9. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis.
Kim WU; Yoo WH; Park W; Kang YM; Kim SI; Park JH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY
J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792
[TBL] [Abstract][Full Text] [Related]
10. Augmented production of chemokines by the interaction of type II collagen-reactive T cells with rheumatoid synovial fibroblasts.
Min DJ; Cho ML; Lee SH; Min SY; Kim WU; Min JK; Park SH; Cho CS; Kim HY
Arthritis Rheum; 2004 Apr; 50(4):1146-55. PubMed ID: 15077296
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
12. T cell proliferative response to type II collagen in the inflammatory process and joint damage in patients with rheumatoid arthritis.
Kim WU; Kim KJ
J Rheumatol; 2005 Feb; 32(2):225-30. PubMed ID: 15693081
[TBL] [Abstract][Full Text] [Related]
13. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
Mathsson L; Lampa J; Mullazehi M; Rönnelid J
Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis.
Strollo R; Ponchel F; Malmström V; Rizzo P; Bombardieri M; Wenham CY; Landy R; Perret D; Watt F; Corrigall VM; Winyard PG; Pozzilli P; Conaghan PG; Panayi GS; Klareskog L; Emery P; Nissim A
Arthritis Rheum; 2013 Jul; 65(7):1702-12. PubMed ID: 23575908
[TBL] [Abstract][Full Text] [Related]
15. [T cell proliferative response and antibody formation to citrullinated collagen type II in patients with rheumatoid arthritis].
Tian X; Zhao Y; Li ZG
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):673-6. PubMed ID: 19595060
[TBL] [Abstract][Full Text] [Related]
16. Anti-Fc gamma receptor III autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid.
Lamour A; Baron D; Soubrane C; Cartron J; Khayat D; Adler Y; Le Goff P; Youinou P
J Autoimmun; 1995 Apr; 8(2):249-65. PubMed ID: 7612151
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between HLA-DR4/1 subtypes and T cell responses to type II collagen or anti-C II 263-272 antibodies].
Li X; Li R; Ning XR; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):582-4. PubMed ID: 16378106
[TBL] [Abstract][Full Text] [Related]
18. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
19. Type II collagen antibody response is enriched in the synovial fluid of rheumatoid joints and directed to the same major epitopes as in collagen induced arthritis in primates and mice.
Lindh I; Snir O; Lönnblom E; Uysal H; Andersson I; Nandakumar KS; Vierboom M; 't Hart B; Malmström V; Holmdahl R
Arthritis Res Ther; 2014 Jul; 16(4):R143. PubMed ID: 25005029
[TBL] [Abstract][Full Text] [Related]
20. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
